Cobro Ventures is a management company that encompasses a diversified portfolio of investments. The firm's investments range from new start-ups to enterprises that have become public and been acquired.
DC, United States
|2017-04-11||Frequency Therapeutics||Series A||$32M||Alexandria Venture Investments, Emigrant Capital, Korea Investment Partners, and Morningside Ventures|
|2016-01-07||C4 Therapeutics||Series A||$73M||Cormorant Asset Management, EG Capital Group, Novartis Venture Funds, Roche Venture Fund, The Kraft Group, and Undisclosed Angel Investors|